Gene: PFKL
Official Full Name: phosphofructokinase, liver typeprovided by HGNC
Gene Summary: This gene encodes the liver (L) subunit of an enzyme that catalyzes the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate, which is a key step in glucose metabolism (glycolysis). This enzyme is a tetramer that may be composed of different subunits encoded by distinct genes in different tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08249 | PFKL Knockout cell line (HeLa) | Human | PFKL | 1:3~1:6 | Negative | Online Inquiry |
KO08250 | PFKL Knockout cell line (HCT 116) | Human | PFKL | 1:2~1:4 | Negative | Online Inquiry |
KO08251 | PFKL Knockout cell line (HEK293) | Human | PFKL | 1:3~1:6 | Negative | Online Inquiry |
KO08252 | PFKL Knockout cell line (A549) | Human | PFKL | 1:3~1:4 | Negative | Online Inquiry |
PFKL Gene Knockout Cell Lines are specialized cellular models engineered through CRISPR-Cas9 technology to specifically disrupt the expression of the phosphofructokinase, liver, and muscle (PFKL) gene. This gene plays a critical role in glycolysis, catalyzing the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, a key regulatory step in glucose metabolism. By inhibiting PFKL, these cell lines serve as vital tools for researchers investigating metabolic pathways, cellular energy homeostasis, and disease conditions related to altered glycolytic activity.
The primary mechanisms of PFKL gene knockout harness the precision of CRISPR-Cas9 gene-editing, allowing for completely ablated gene expression without off-target effects, providing researchers with a robust model for studying the functional consequences of PFKL deficiency. These cell lines enable the exploration of metabolic flux changes, alterations in cellular signaling cascades, and responses to different stressors, thereby offering critical insights into diseases such as cancer, diabetes, and cardiovascular disorders.
The scientific importance of PFKL Gene Knockout Cell Lines extends to various research domains including metabolic engineering, pharmacological testing, and biomarker discovery. Their application in preclinical studies allows for the validation of therapeutic targets and the assessment of drug efficacy, leading to potential breakthroughs in personalized medicine.
One of the unique selling points of PFKL Gene Knockout Cell Lines is their validated performance, facilitating reproducible results across experimental setups. This reliability is critical for researchers aiming to generate publishable data quickly and accurately. Compared to other knockout models, our PFKL lines offer significant advantages such as lower variability and enhanced functional relevance, driven by our commitment to utilizing cutting-edge gene editing techniques.
For researchers and clinicians, utilizing PFKL Gene Knockout Cell Lines means access to a powerful platform that provides unparalleled insight into metabolic disorders. Our dedicated team, with extensive expertise in gene editing and cell line development, ensures that each product meets high-quality standards, fostering innovation and driving advancement in scientific discovery. By choosing our PFKL Gene Knockout Cell Lines, users gain not just a product, but a partner in research excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.